Document is current
Any future updates will be listed below
-
Authors
Raftery, Kay A.
Levy, Hannah
Singh, Rananjay
Madi, Mohammed
Slater, Thomas D.
Crossman, Antony J.
Kedgley, Angela E.
Freedman, Brett A.
Newell, Nicolas
-
Funding
Funding for this research was provided by:
the Engineering and Physical Sciences Research Council New Investigator Award (EP/V029452/1)
Back to Back
- License Information
-
More Information
Article History
Received: 15 October 2025
Revised: 17 December 2025
Accepted: 23 December 2025
First Online: 9 January 2026
Declarations
:
: BF has received consultant honorarium from Medtronic, for which they receive personal compensation. Outside the submitted work, BF also reports stock ownership of Clear Choice therapeutics, has received consultant honorarium from Synthes, Kuros, and Amgen, and is on the Scientific Advisory board of Theradaptive.
